IssuerAnnouncementDetailsV2Portlet
Al Hammadi Holding Announces an update on acquiring 40% of Wareed Medical Company (a limited liability company).
| Element List | Explanation |
|---|---|
| Introduction | With reference to the company’s announcement published on the Saudi Exchange website on 03/12/2025 regarding the signing of a share subscription agreement in Wareed Medical Company to acquire a 40% stake in the company’s shares, in addition to signing a shareholders’ agreement to regulate the relationship between the shareholders and the mechanism of managing the company during the coming period. The Company announce that; it received the No-Objection Certificate issued by the General Authority for Competition regarding the acquisition of a 40% stake in Wareed Medical Company (a limited liability company). The Company is currently completing the necessary contractual and regulatory procedures in preparation for amending the articles of association of Wareed Medical Company, and any material developments related to this transaction will be announced in due course. |
| Previous Announcement | acquiring 40% of Wareed Medical Company (a limited liability company). |
| Date of Previous Announcement on Saudi Exchange’s Website | 2025-12-03 Corresponding to 1447-06-12 |
| Hyperlink to the Previous Announcement on the Saudi Exchange Website | Click Here |
| Latest Developments Of The Announced Event | The Company announce that, it received the No-Objection Certificate issued by the General Authority for Competition regarding the acquisition of a 40% stake in Wareed Medical Company (a limited liability company). |
| The costs associated with the event, and if they have changed or not with indication of the reasons. | The financial impact of the transaction on the company and its operations will be determined after the completion of the transaction. |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.